Yimmugo

Yimmugo is a human normal immunoglobulin solution for intravenous use. It provides passive immunity by supplying antibodies to support immune function. This EU-sourced therapy is used in clinical settings for immune deficiencies and related conditions.

Human normal immunoglobulin (Yimmugo) is used to treat primary immunodeficiency disorders where the body lacks sufficient antibodies. It may also support patients with secondary immunodeficiencies or autoimmune conditions requiring immune modulation. This therapy helps restore immune function by providing broad-spectrum antibodies derived from healthy donors.

Yimmugo works by supplying functional antibodies that temporarily enhance the immune system’s ability to fight infections. Patients may experience improved resistance to common pathogens while receiving treatment. The effects are temporary and require regular administration to maintain immune support.

Store Yimmugo refrigerated between 2°C and 8°C and protect from light. Do not freeze. Always check the solution for particles or discoloration before use. Administer under medical supervision to monitor for potential reactions. Ensure proper handling to maintain sterility throughout use.

Yimmugo may interact with live vaccines, potentially reducing their effectiveness. Avoid concurrent use with immunosuppressive therapies unless directed by a healthcare provider. Monitor closely when combining with other blood products or immune-modulating drugs. Discuss all medications with your clinician before starting Yimmugo.